Wolverine Asset Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
Wolverine Asset Management's TDACW Position: Q2 2026 in Review
Wolverine Asset Management sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 103,336 shares — an estimated $12.4K sold.
Wolverine Asset Management first reported a position in TDACW in Q2 2025 and held it in 4 quarters. The position peaked at $41.7K in Q3 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.
- Wolverine Asset Management reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
- Wolverine Asset Management sold 103,336 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $12.4K.
- Wolverine Asset Management first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and held it in 4 quarters.
- Wolverine Asset Management's Translational Development Acquisition Corp Warrants position peaked at $41.7K in Q3 2025.
- 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.
Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.